Skip to content
Search AI Powered

Latest Stories

Manisha Koirala joins UK cancer charity Ovacome as ambassador

As part of her voluntary role, Koirala will engage with cancer patients and survivors, sharing her experiences and raising awareness about the disease.

Manisha-Koirala-Ovacome

Ovacome’s CEO, Victoria Clare, welcomed Koirala’s appointment, highlighting the impact her advocacy could have

BOLLYWOOD actor Manisha Koirala has been announced as the new ambassador for Ovacome, the UK-based ovarian cancer support charity.

Koirala, who overcame stage 4 ovarian cancer nearly a decade ago, will work with the organisation to support patients, promote early detection, and address health inequalities.


Each year, around 7,500 people in the UK are diagnosed with ovarian cancer. As part of her voluntary role, Koirala will engage with cancer patients and survivors, sharing her experiences and raising awareness about the disease. Her work will also focus on improving knowledge of symptoms to help with earlier diagnoses.

Speaking about her new role, Koirala said, “I want to use my voice to support cancer patients and raise awareness about the need for equitable healthcare access and the importance of knowing the signs and symptoms of ovarian cancer. Having faced cancer myself, I know how isolating and challenging the journey can be.”

Ovacome’s CEO, Victoria Clare, welcomed Koirala’s appointment, highlighting the impact her advocacy could have. “Manisha’s decision to share her own experience and challenge the stigma associated with the disease is deeply inspiring. We look forward to working together to improve equitable access to diagnosis and treatment,” Clare said.

Ovacome supporter Preeti added that Koirala’s global influence, particularly in diverse communities, could help break stigmas surrounding ovarian cancer and encourage earlier diagnosis.

Koirala, known for her roles in Bollywood and her latest Netflix series Heeramandi, has previously shared her journey in her memoir, Healed. She was also honoured in British Parliament last year for her resilience and contributions to cinema.

Ovacome offers support services, including a helpline, online forums, and awareness campaigns. More information can be found on their website.

More For You

brain-structures-at-birth-getty

Researchers from the University of Cambridge, UK, examined brain scans of over 500 newborns—236 girls and 278 boys—aged between 0 and 28 days. (Representational image: iStock)

Girls have more grey matter, boys more white matter at birth: Study

A NEW study has found that newborn girls and boys have distinct brain structures at birth. While boys tend to have larger brains with more white matter, girls have significantly more grey matter, which is linked to learning, speech, and cognition.

Published in the journal Biology of Sex Differences, the study suggests these differences may result from biological sex-specific development in the womb.

Keep ReadingShow less
nhs-hospital-getty

NHS faces pressure as flu admissions rise sharply

FLU cases in the country have surged, with over 5,000 hospital admissions last week, marking a sharp increase as the NHS faces pressure from a winter quad-demic of flu, Covid, respiratory syncytial virus (RSV), and norovirus.

According to The Times, flu admissions rose from 4,102 on Christmas Day to 5,074 by 29 December.

Keep ReadingShow less
AI spots heart conditions before symptoms appear

The trial sees the AI system scanning GP records at multiple surgeries in West Yorkshire (Photo for representation: iStock)

AI spots heart conditions before symptoms appear

A NEW artificial intelligence (AI) tool is revolutionising the early detection of atrial fibrillation (AF), a common heart condition linked to a heightened risk of stroke.

This innovative approach is currently undergoing trials in West Yorkshire, where it analyses patient records to spot early warning signs of AF, even before symptoms develop, reported the Telegraph.

Keep ReadingShow less
AI-diabetes-risk-tool-iStock

World's first AI diabetes risk tool to be tested by NHS in 2025

THE NHS in England is set to launch a world-first trial of an artificial intelligence (AI) tool that predicts the risk of developing type 2 diabetes up to 13 years before symptoms appear.

The trial, scheduled for 2025, will take place at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust, The Guardian reported.

Keep ReadingShow less
Study estimates autism affects one in 127 globally

The disorder is associated with repetitive behaviour and affected social skills.

(Photo for representation: iStock)

Study estimates autism affects one in 127 globally

A STUDY has estimated that one in every 127 people globally, or 6.18 crore individuals, had autism in 2021, with the neurodevelopmental condition featuring among the top 10 causes of non-fatal health burden in youth aged under 20 years.

The disorder is associated with repetitive behaviour and affected social skills. Signs, which can begin to show as early as 12 months of age, include poor non-verbal communication, such as avoiding eye contact and not responding to their name.

Keep ReadingShow less